PUBLIC CONTRACT · 2025

Aquisição de OZANIMOD 0,92MG CAPS OR, Upadacitinib 15mg comp LP OR, IBRUTINIB 420MG COMP OR e VENETOCLAX 100MG COMP OR, ao abrigo do acordo quadro 2023/491

Contract value
€61,879.74
Signed on
30 October 2025
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 12180716

PUBLISHED SUBJECT

Aquisição de OZANIMOD 0,92MG CAPS OR, Upadacitinib 15mg comp LP OR, IBRUTINIB 420MG COMP OR e VENETOCLAX 100MG COMP OR, ao abrigo do acordo quadro 2023/491

Parties involved

Place of performance
Portugal, Braga, Braga
NUTS region
PT112 - Cávado

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
JANSSEN CILAG FARMACÊUTICA, LDA. · Tax ID 500189412
Bidder
Abbvie, Lda · Tax ID 510229050

Values and timeline

Contract price
€61,879.74
Procedure base price
€570,816.67
Total effective price
Not reported on Portal BASE
Publication date
22 December 2025
Award date
30 October 2025
Signing date
30 October 2025
Performance period
90 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7907805

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts